Analyst Expect Big Moves From Galectin Therapeutics Inc (NASDAQ: GALT)
Currently, there are 63.29M common shares owned by the public and among those 43.42M shares have been available to trade. The company’s stock has a 5-day price change of 78.36% and 51.27% over the past three months. GALT shares are trading 85.27% year to date (YTD), with the 12-month market performance down to -10.15% lower. […]